首页> 美国卫生研究院文献>Scientific Reports >Lipid vesicles containing transferrin receptor binding peptide TfR-T12 and octa-arginine conjugate stearyl-R8 efficiently treat brain glioma along with glioma stem cells
【2h】

Lipid vesicles containing transferrin receptor binding peptide TfR-T12 and octa-arginine conjugate stearyl-R8 efficiently treat brain glioma along with glioma stem cells

机译:含有运铁蛋白受体结合肽TfR-T12和八-精氨酸共轭硬脂酸R8的脂质囊泡可有效治疗脑胶质瘤和神经胶质瘤干细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Surgery and radiotherapy cannot fully remove brain glioma; thus, chemotherapy continues to play an important role in treatment of this illness. However, because of the restriction of the blood-brain barrier (BBB) and the regeneration of glioma stem cells, post-chemotherapy relapse usually occurs. Here, we report a potential solution to these issues that involves a type of novel multifunctional vinblastine liposomes equipped with transferrin receptor binding peptide TfR-T12 and octa-arginine conjugate stearyl-R8. Studies were performed on brain glioma and glioma stem cells in vitro and were verified in brain glioma-bearing mice. The liposomes were transported across the BBB, killing brain glioma and glioma stem cells via the induction of necrosis, apoptosis and autophagy. Furthermore, we reveal the molecular mechanisms for treating brain glioma and glioma stem cells via functionalized drug lipid vesicles.
机译:手术和放疗不能完全清除脑胶质瘤;因此,化学疗法继续在该疾病的治疗中起重要作用。但是,由于血脑屏障(BBB)的限制和神经胶质瘤干细胞的再生,通常会发生化学疗法后的复发。在这里,我们报告这些问题的潜在解决方案,涉及一种新型的多功能长春碱脂质体,配备转铁蛋白受体结合肽TfR-T12和八-精氨酸共轭硬脂基-R8。在体外对脑胶质瘤和神经胶质瘤干细胞进行了研究,并在带有脑胶质瘤的小鼠中得到了证实。脂质体通过诱导坏死,凋亡和自噬,被转运至血脑屏障,杀死脑神经胶质瘤和神经胶质瘤干细胞。此外,我们揭示了通过功能化的药物脂质囊泡治疗脑神经胶质瘤和神经胶质瘤干细胞的分子机制。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号